Mature B-Cell Neoplasm

2

Review clinical trials related to Mature B-Cell Neoplasm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

The purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD) of SGR-1505.

Participants needed: 98
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Schrödinger, Inc.Updated: Feb 13, 2026Locations: 36
Eligibility criteria

Subject must have a history of histologically or cytologically confirmed mature... [+3]

The subject is in need of immediate cytoreductive therapy (unless the patient ha... [+4]

Status: Recruiting

Liquid Biopsy in Mature B-cell Tumors

The study aims at assessing whether cell free DNA genotyping can improve the accuracy of early prediction of cure in mature B-cell tumor patients and whether it represents an accessible source of tumor DNA for the sensitive identification of genetic biomarkers that refine the diagnostic workup, stratify prognosis and identify the emergence of drug-resistance mutations during treatment.

Participants needed: 444
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Oncology Institute of Southern SwitzerlandUpdated: Nov 1, 2023Locations: 1
Eligibility criteria

Male or female adults 18 years or older [+3]